HYPOSPLENISM

HYPOSPLENISM was reported 39 times

HYPOSPLENISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cannabinoid [EPC] 8 0.0010
1 Erythroid Maturation Agent [EPC] 1 0.0004
2 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 1 0.0003
3 CD30-directed Immunoconjugate [EPC] 3 0.0003
4 Somatostatin Analog [EPC] 1 0.0001
5 Provitamin D2 Compound [EPC] 2 0.0001
6 Polyene Antifungal [EPC] 2 0.0000
7 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
8 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
9 Corticosteroid [EPC] 26 0.0000
10 Janus Kinase Inhibitor [EPC] 3 0.0000
11 Complement Inhibitor [EPC] 1 0.0000
12 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
13 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
14 Alkylating Drug [EPC] 3 0.0000
15 Factor Xa Inhibitor [EPC] 3 0.0000
16 Interleukin-23 Antagonist [EPC] 1 0.0000
17 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
20 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
21 Calcium [EPC] 1 0.0000
22 Vitamin D [EPC] 2 0.0000
23 Azole Antifungal [EPC] 1 0.0000
24 Vitamin B12 [EPC] 2 0.0000
25 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
26 Kinase Inhibitor [EPC] 3 0.0000
27 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
28 Proton Pump Inhibitor [EPC] 3 0.0000
29 Vitamin C [EPC] 2 0.0000
30 Benzodiazepine [EPC] 3 0.0000
31 Platinum-based Drug [EPC] 1 0.0000
32 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
33 Osmotic Laxative [EPC] 1 0.0000
34 Atypical Antipsychotic [EPC] 1 0.0000
35 Loop Diuretic [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000